When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mainly used to make the site work as you expect it to. The information does not directly identify you but can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to learn more and change our default settings. However, blocking some types of cookies may impact your experience of the site. You can find more information, including a detailed cookie explanation, on our Cookie Policy.
About us
We share an ambition to transform healthcare and improve human lives through AI-guided precision solutions.
About Quibim
At Quibim, we design pioneering tools that unlock imaging data to improve patient outcomes.
After years of intense research in imaging biomarkers, Quibim (QUantitative Imaging Biomarkers In Medicine) did the commercial launch and internationalization in 2021. Our main purpose is the application of AI techniques to medical images from MRI, CT, PET to unlock new data which can be transformed into actionable predictions for life sciences and providers. The business model is based on a platform marketed through SaaS for hospitals and value-based partnerships in life sciences that help to identify new market needs and create new algorithms.
Having expanded internationally and with a growing team, we are now heading up to bring a new line of products based on predictive imaging biomarker panels.